Gurtej Singh, MD
Cardiovascular Disease · Evansville, INNPI 1497941728
Payments from drug & device makers
Across 16 payments — averaging $262.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avita Medical Americas, LLC$3K
- Globus Medical$146
- Nevro Corp.$143
- Integra Lifesciences Corporation$138
- Organogenesis Inc.$125
- MML US, Inc.$98
- plus $93 from 2 others
What the payments were for
- Consulting fees$3,00071%
- Travel & lodging$45511%
- Food & beverage$74318%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avita Medical Americas, LLC | 4 | $3,455 |
| Globus Medical | 6 | $146 |
| Nevro Corp. | 1 | $143 |
| Integra Lifesciences Corporation | 1 | $138 |
| Organogenesis Inc. | 1 | $125 |
| MML US, Inc. | 1 | $98 |
| Abbott | 1 | $80 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RECELL$3,455
- PERMEADERM$1,455
- Cohealyx$1,455
- INTEGRA$415
- Omnia$143
- INTEGRA DERMAL REGENERATION TEMPLATE$138
- PRIMATRIX$138
- PURAPLY WOUND MATRIX$125
How this compares
$4,199 in reported general payments places this provider in the 55th percentile of 408 cardiovascular disease providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MultaqDronedarone Hcl | 57 | $101,157 |
| EntrestoSacubitril/Valsartan | 30 | $49,720 |
| JardianceEmpagliflozin | 77 | $44,546 |
| Repatha SureclickEvolocumab | 43 | $35,208 |
| BrilintaTicagrelor | 13 | $12,134 |
| EliquisApixaban | 12 | $8,765 |
| PradaxaDabigatran Etexilate Mesylate | 28 | $7,553 |
| Amiodarone Hcl | 153 | $4,318 |
| Flecainide Acetate | 77 | $3,223 |
| Ranolazine ErRanolazine | 38 | $2,111 |
| Metoprolol Succinate | 168 | $1,859 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 45 | $1,243 |
| Atorvastatin Calcium | 89 | $1,148 |
| SotalolSotalol Hcl | 46 | $1,137 |
| Cartia XtDiltiazem Hcl | 18 | $726 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Evansville
- Douglas ShefferEvansville$138K
- John McGintyRichmond$3.7M
- Steven SteinhublLafayette$2.4M
- Ravi BhagwatMunster$2.2M
- Mohan KesaniMunster$1.2M
- Vijay MehtaElkhart$925K
- William CollisFort Wayne$842K
- Atul ChughIndianapolis$775K
- Noel DasguptaIndianapolis$744K
- Wail AsfourMunster$736K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.